KRAS G12C LUNG CANCER

Clinical trials for KRAS G12C LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new KRAS G12C LUNG CANCER trials appear

Sign up with your email to follow new studies for KRAS G12C LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for KRAS lung cancer: targeted combo takes on chemo in major trial

Disease control Recruiting now

This study tests whether a new drug (divarasib) combined with immunotherapy (pembrolizumab) works better than standard chemotherapy plus immunotherapy for people with a specific genetic mutation (KRAS G12C) in advanced non-small cell lung cancer. About 600 adults who have not had…

Matched conditions: KRAS G12C LUNG CANCER

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

KRAS G12C LUNG CANCER

Get alerted when new KRAS G12C LUNG CANCER trials appear

New hope for KRAS lung cancer: targeted combo takes on chemo in major trial